Article
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
Antimicrobial agents and chemotherapy - 1 Apr 2017
Johnson J Kristie, Robinson Gwen L, Pineles Lisa L, Ajao Adebola O, Zhao LiCheng, Albrecht Jennifer S, Harris Anthony D, Thom Kerri A, Furuno Jon P
Abstract excerpt
Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae strains are increasing in prevalence worldwide. Carbapenem antibiotics are used as a first line of therapy against ESBL-producing Enterobacteriaceae We examined a cohort of critical care patients for gastrointestinal colonization with carbapenem-resistant ESBL-producing strains (CR-ESBL strains). We cultured samples from this cohort of patients for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
